Also, the genetic and pharmacological inhibition of TREK-1 alters depression-related behaviors and neuronal plasticity in mice, indicating the significance of these channels as therapeutic targets for neuronal disorders [20]. This evidence concerns the gene KCNK2 and major depressive disorder.